没有数据	没有数据

没有数据	没有数据

来源	SDS样本
没有数据	没有数据

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

High-throughput screening of myometrial calcium-mobilization to identify modulators of uterine contractilityHerington J L, et al. Testing, 10(11) (2015) Characterization of the rapidly activating delayed rectifier potassium current, I (Kr), in HL-1 mouse atrial myocytes.Futoshi Toyoda et al.The Journal of membrane biology, 235(2), 73-87 (2010-05-22) T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.Mitsuru Horiba et al.Life sciences, 82(11-12), 554-560 (2008-02-16) Adenoviral-mediated expression of dihydropyridine-insensitive L-type calcium channels in cardiac ventricular myocytes and fibroblasts.Kenneth B Walsh et al.European journal of pharmacology, 565(1-3), 7-16 (2007-04-03) Nisoldipine: a new dihydropyridine calcium-channel blocker.J Mitchell et al.Journal of clinical pharmacology, 33(1), 46-52 (1993-01-01) Characterization of the rapidly activating delayed rectifier potassium current, I (Kr), in HL-1 mouse atrial myocytes.Futoshi Toyoda et al.The Journal of membrane biology, 235(2), 73-87 (2010-05-22) High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility.Jennifer L Herington et al.PloS one, 10(11), e0143243-e0143243 (2015-11-26) Effect of nisoldipine and olmesartan on endothelium-dependent vasodilation in essential hypertensive patients.Duo Wei et al.CNS neuroscience & therapeutics, 18(5), 400-405 (2012-04-27) Influence of cilnidipine or nisoldipine on sympathetic activity in healthy male subjects.Tsuyoshi Shiga et al.Heart and vessels, 22(6), 404-409 (2007-11-29) Actions of nisoldipine in cardiovascular disease.D J Duncker et al.The Canadian journal of cardiology, 5(5), 266-274 (1989-06-01) The inhibitory effects of m-nisoldipine on the 5-hydroxytryptamine-induced proliferation of pulmonary artery smooth muscle cells via Ca2+ antagonism and antioxidant mechanisms.Xueyan Chen et al.European journal of pharmacology, 686(1-3), 32-40 (2012-05-12) Simultaneous determination of m-nisoldipine and its three metabolites in rat plasma by liquid chromatography-mass spectrometry.Dezhi Kong et al.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(29), 2989-2996 (2010-09-28) Role of action potential configuration and the contribution of C²⁺a and K⁺ currents to isoprenaline-induced changes in canine ventricular cells.N Szentandrássy et al.British journal of pharmacology, 167(3), 599-611 (2012-05-09) High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility.Jennifer L Herington et al.PloS one, 10(11), e0143243-e0143243 (2015-11-26) Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.H D Langtry et al.Drugs, 53(5), 867-884 (1997-05-01) Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.B S Lewis The American journal of cardiology, 75(13), 46E-53E (1995-04-27) Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.S F Hamilton et al.Heart disease (Hagerstown, Md.), 1(5), 279-288 (2001-11-27) Clinical pharmacokinetics of nisoldipine coat-core.R Heinig Clinical pharmacokinetics, 35(3), 191-208 (1998-10-24) Engineering of human cardiac muscle electromechanically matured to an adult-like phenotypeRonaldson B K, et al. Nature Protocols, 14(10), 2781-2817 (2019) Serum phosphorus and cardiovascular mortality in type 2 diabetes.Michel Chonchol et al.The American journal of medicine, 122(4), 380-386 (2009-04-01) Pharmacologic agents in the management of hypertension--nisoldipine coat-core.William B White Journal of clinical hypertension (Greenwich, Conn.), 9(4), 259-266 (2007-03-31) Mobilization of putative high-proliferative-potential endothelial colony-forming cells during antihypertensive treatment in patients with essential hypertension.Ralf A Benndorf et al.Stem cells and development, 16(2), 329-338 (2007-05-25) New phenotypic cytotoxicity assay for ROS-inducing compounds using rat renal epithelial cells.Noriko Uchiyama et al.Toxicology letters, 331, 227-234 (2020-06-12) High-throughput screening of myometrial calcium-mobilization to identify modulators of uterine contractilityHerington J L, et al. PLoS ONE, 10(11) (2015) Fast disintegrating tablets of nisoldipine for intra-oral administration.Gamal M El Maghraby et al.Pharmaceutical development and technology, 19(6), 641-650 (2013-07-12) New Phenotypic Cytotoxicity Assay for ROS-inducing Compounds using Rat Renal Epithelial CellsUchiyama N, et al. Toxicology Letters, 10(11) (2020) Why is nisoldipine a specific agent in ischemic left ventricular dysfunction?A M Knorr The American journal of cardiology, 75(13), 36E-40E (1995-04-27) Nisoldipine CC: clinical experience in hypertension.J Langan et al.Cardiology, 88 Suppl 1, 56-62 (1997-01-01) The pharmacology of nisoldipine.A Knorr Cardiovascular drugs and therapy, 1(4), 393-402 (1987-12-01) Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs.Shruti Chopra et al.International journal of pharmaceutics, 446(1-2), 136-144 (2013-02-21) Nisoldipine exposures.Michael A Miller et al.The American journal of emergency medicine, 26(3), 367-368 (2008-03-25) [Effect of m-nisoldipine on the Ca2+/CaM/CaN signal pathway in 5-HT-induced proliferation of rat PASMCs].Xue-Yan Chen et al.Yao xue xue bao = Acta pharmaceutica Sinica, 45(1), 49-54 (2011-03-01) Gingival hyperplasia in a patient with hypertension.A H Tajani et al.Journal of clinical hypertension (Greenwich, Conn.), 10(11), 863-865 (2009-01-09) What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?L H Opie The American journal of cardiology, 79(10A), 29-32 (1997-05-22) Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.J G Fodor Cardiovascular drugs and therapy, 10 Suppl 3, 873-879 (1997-01-01) Nisoldipine coat core as concomitant therapy in chronic stable angina pectoris.S P Glasser The American journal of cardiology, 75(13), 68E-70E (1995-04-27) Tissues distribution of R-(-)- and S-(+)-m-nisoldipine after single enantiomer administration in rats.Min Li et al.Drug development and industrial pharmacy, 35(1), 65-72 (2008-09-30) Nisoldipine CC: clinical experience in ischaemic heart disease.A Melcher et al.Cardiology, 88 Suppl 1, 17-23 (1997-01-01) Nisoldipine in severe ischaemic left ventricular dysfunction.H Pouleur et al.European heart journal, 14 Suppl A, 45-47 (1993-07-01) Clinical pharmacology of nisoldipine coat core.F Zannad The American journal of cardiology, 75(13), 41E-45E (1995-04-27) Telmisartan improves endothelial function in patients with essential hypertension.Ralf A Benndorf et al.Journal of cardiovascular pharmacology, 50(4), 367-371 (2007-12-01) Effects of three metabolites of propiverine on voltage-dependent L-type calcium currents in human atrial myocytes.Melinda Wuest et al.European journal of pharmacology, 598(1-3), 94-97 (2008-09-18) Engineering of human cardiac muscle electromechanically matured to an adult-like phenotype.Kacey Ronaldson-Bouchard et al.Nature protocols, 14(10), 2781-2817 (2019-09-08) Tetrodotoxin blocks L-type Ca2+ channels in canine ventricular cardiomyocytes.Bence Hegyi et al.Pflugers Archiv : European journal of physiology, 464(2), 167-174 (2012-05-23) Anti-arrhythmic and hemodynamic effects of oxy nifedipine, oxy nimodipine, oxy nitrendipine and oxy nisoldipine.Katarzyna A Mitręga et al.Pharmacological research, 66(4), 300-308 (2012-07-04) Capillary electrophoretic enantioseparation of m-nisoldipine using two different beta-cyclodextrins.Dezhi Kong et al.Journal of separation science, 32(18), 3178-3183 (2009-09-12) [Clinical pharmacology of nisoldipine, a new calcium antagonist].K Iu Krivonkin et al.Kardiologiia, 31(9), 100-105 (1991-09-01) [Nisoldipine in comparison with long-term nitrates].B Eber et al.Acta medica Austriaca, 19(5), 137-139 (1992-01-01) Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.G L Plosker et al.Drugs, 52(2), 232-253 (1996-08-01) Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.H A Friedel et al.Drugs, 36(6), 682-731 (1988-12-01) Preparation of a novel glycidyl methacrylate-based monolith and its application for the determination of m-nisoldipine in human plasma.Qiaoxia Zhang et al.Journal of chromatographic science, 48(6), 517-522 (2010-09-09) Nisoldipine: a new dihydropyridine calcium-channel blocker.J Mitchell et al.Journal of clinical pharmacology, 33(1), 46-52 (1993-01-01)

备注